New treatment option for Acute Decompensated Heart Failure
Official title Low Level Tragus Stimulation in Acute Decompensated Heart Failure
ClinicalTrials.gov ID: NCT02898181
What this study is testing
- What it's testing
- Acute Decompensated Heart Failure (ADHF) is a major cause of morbidity and mortality. It is associated with increased systemic inflammation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients admitted with ADHF
You likely can't join if
- Refusal to consent
- Complex congenital heart disease (Tetralogy of Fallot patients, single ventricle physiology)
- Recurrent vaso-vagal syncopal episodes
- Unilateral or bilateral vagotomy
- Sick sinus syndrome
- 2nd or 3rd degree AV block
See the full eligibility criteria
- Patients admitted with ADHF
- Refusal to consent
- Complex congenital heart disease (Tetralogy of Fallot patients, single ventricle physiology)
- Recurrent vaso-vagal syncopal episodes
- Unilateral or bilateral vagotomy
- Sick sinus syndrome
- 2nd or 3rd degree AV block
- bifascicular block or prolonged 1st degree AV block (PR\>300ms)
- Pregnant patients
- Prisoners
- Advanced renal dysfunction(defined as eGFR \< 30, stage 4 or 5 chronic kidney disease)
- Hepatitis C or HIV
- Acute Myocardial infarction
The study team makes the final eligibility decision.
Where it's taking place
- Oklahoma City, Oklahoma, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oklahoma City, Oklahoma, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.